BioTek Instruments Announces New Scientific Director
November 10, 2008
"Dr. Banks’ outstanding scientific leadership, strategic vision and industry expertise make him a welcome addition to our team," said Briar Alpert, President and CEO of BioTek. "We can now strengthen our commitment to our customers even further, and continue to provide significant solutions for their applications."
Before joining BioTek, he served as Technology Leader, Bio-discovery with PerkinElmer Life and Analytical Sciences, where he played a principle role in strategic and product development activities. From 2002 to 2005, Dr. Banks held a series of leadership roles with PerkinElmer, Inc., including R&D Manager in Montreal and R&D Portfolio Leader for the Life Sciences business.
Dr. Banks holds both a B.Sc. in Chemistry and a Ph.D. in Analytical Chemistry from the University of British Columbia. He also has affiliations with the Society for Biomolecular Screening, Association for Laboratory Automation, American Chemical Society, and the American Society for Mass Spectrometry.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research. Founded in 1968, BioTek Instruments is celebrating its 40th anniversary this year.
For further information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications